Notably, Foxo1M-KO reduced liver fibrosis in HFD-challenged livers, as shown by Sirius red, Masson’s trichrome, and α-smooth muscle actin (αSMA) staining (Fig. 2d). Here, ACTA1 is linked to Hepatic fibrosis.